E-6742

N/A

Report date: 2026/04/29 20:02:18
NME

Base Information

Drug NameE-6742
Drug Alias NameE-6742
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 8 antagonistsToll like receptor 7 antagonists
TargetsToll like receptor 8Toll like receptor 7
Therapy Area/IndicationsAutoimmune DiseasesLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEisai Co LtdEisai China Inc
Inactive CompaniesEisai Inc
Active IndicationsLupus Erythematosus, Systemic
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A